21m
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that it has submitted a marketing authorization application (MAA) in Europe for TLX101-Px ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results